AvandiaŽ Preclinical Findings - Highlights
Rosiglitazone has greater pharmacological potency and a better hepatic safety profile than troglitazone
Some preclinical findings are common to the thiazolidinediones
Preclinical studies predicted efficacy and safety in clinical trials